Compare Lustrum:Astellas Pharma Inc.:4503

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Astellas Pharma Inc. Go to web site 4503 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Astellas Pharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Balance Sheet 2024年3月期 Astellas Pharma Inc. Balance Sheet 2023年3月期 Astellas Pharma Inc. Balance Sheet 2022年3月期 Astellas Pharma Inc. Balance Sheet 2021年3月期 Astellas Pharma Inc. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
335,687down
(9.4%)down
376,840up
(15.3%)up
315,986down
(13.5%)down
326,128up
(14.3%)up
318,391
(13.8%)
Other Current AssetsHelp
(Percent)
859,043up
(24.1%)down
673,114up
(27.4%)up
607,368up
(26.0%)up
546,460down
(24.0%)up
549,123
(23.7%)
Tangible Fixed AssetsHelp
(Percent)
293,742up
(8.2%)down
286,459up
(11.7%)up
269,044up
(11.5%)down
264,623down
(11.6%)up
268,600
(11.6%)
Intangible Fixed AssetHelp
(Percent)
1,453,824up
(40.7%)up
562,496down
(22.9%)down
623,431down
(26.7%)down
651,427down
(28.7%)down
724,773
(31.3%)
Investments and OthersHelp
(Percent)
208,613down
(5.8%)down
229,198up
(9.3%)up
213,536up
(9.2%)up
200,979up
(8.8%)up
176,029
(7.6%)
Total AssetsHelp
(Percent)
3,569,603
(100%)
2,456,518
(100%)
2,332,395
(100%)
2,273,628
(100%)
2,315,169
(100%)
Total Current LiabilitiesHelp
(Percent)
1,525,877up
(42.7%)up
808,640up
(32.9%)down
776,201up
(33.3%)up
688,492down
(30.3%)down
896,729
(38.7%)
Total Long-term LiabilitiesHelp
(Percent)
447,738up
(12.5%)up
139,924up
(5.7%)up
95,886down
(4.1%)down
199,021up
(8.8%)up
129,272
(5.6%)
Shareholder's EquityHelp
(Percent)
1,595,988up
(44.7%)down
1,507,954up
(61.4%)down
1,460,308up
(62.6%)up
1,386,115up
(61.0%)up
1,289,168
(55.7%)
Total LiabilitiesHelp
(Percent)
3,569,603
(100%)
2,456,518
(100%)
2,332,395
(100%)
2,273,628
(100%)
2,315,169
(100%)

Astellas Pharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Profit and Loss Account 2024年3月期 Astellas Pharma Inc. Profit and Loss Account 2023年3月期 Astellas Pharma Inc. Profit and Loss Account 2022年3月期 Astellas Pharma Inc. Profit and Loss Account 2021年3月期 Astellas Pharma Inc. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
1,603,672
(100%)
1,518,619
(100%)
1,296,163
(100%)
1,249,528
(100%)
1,300,843
(100%)
Total Sales
(Percent)
1,603,672
(100%)
1,518,619
(100%)
1,296,163
(100%)
1,249,528
(100%)
1,300,843
(100%)
Cost of SalesHelp
(Percent)
292,485up
(18.2%)down
288,353up
(19.0%)down
253,009up
(19.5%)down
246,063down
(19.7%)down
276,739
(21.3%)
Other Costs and RevenueHelp 1,294,142up
(80.7%)up
1,131,552up
(74.5%)up
919,068up
(70.9%)up
882,875up
(70.7%)up
828,693
(63.7%)
Total CostsHelp 1,586,627 1,419,905 1,172,077 1,128,938 1,105,432
Net RevenueHelp 1,311,187up
(81.8%)up
1,230,266up
(81.0%)up
1,043,154up
(80.5%)up
1,003,465down
(80.3%)up
1,024,104
(78.7%)
Earnings Before TaxHelp 24,969down
(1.6%)down
132,361down
(8.7%)down
156,886up
(12.1%)up
145,324down
(11.6%)down
245,350
(18.9%)
Net IncomeHelp 17,045down
(1.1%)down
98,714down
(6.5%)down
124,086up
(9.6%)down
120,590down
(9.7%)down
195,411
(15.0%)
当期純利益 17,045 98,714 124,086 120,590 195,411

Astellas Pharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Cash Flow Statement 2024年3月期 Astellas Pharma Inc. Cash Flow Statement 2023年3月期 Astellas Pharma Inc. Cash Flow Statement 2022年3月期 Astellas Pharma Inc. Cash Flow Statement 2021年3月期 Astellas Pharma Inc. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
172,476down
(20.4%)down
327,767up
(96.1%)up
257,443down
(92.4%)down
306,843up
(96.2%)up
221,997
(55.1%)
Investing Cash Flow(ICF)Help
(Percent)
-845,802down
(-100.0%)down
-84,500down
(-24.8%)down
-62,413up
(-22.4%)up
-81,894up
(-25.7%)up
-389,793
(-96.7%)
Financing Cash FlowHelp
(Percent)
614,060up
(72.6%)up
-195,623up
(-57.4%)up
-216,298up
(-77.6%)down
-229,479down
(-71.9%)down
181,055
(44.9%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
18,113up
(2.1%)down
13,210up
(3.9%)down
11,125down
(4.0%)up
12,267up
(3.8%)up
-5,942
(-1.5%)
Net Increase and Decrease in Cash and Cash Equivalentsn -41,153down
(-4.9%)down
60,854up
(17.8%)up
-10,143down
(-3.6%)down
7,737up
(2.4%)up
7,317
(1.8%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Astellas Pharma Inc.

Company where related level is highHelp

BIOFERMIN PHARMACEUTICAL CO.,LTD.
ONO PHARMACEUTICAL CO.,LTD.
Fuji Pharma Co.,Ltd.
Eisai Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.
Kringle Pharma,Inc.
Modalis Therapeutics Corporation
SEIKAGAKU CORPORATION
MUROMACHI CHEMICALS INC.
BrightPath Biotherapeutics Co., Ltd.